Address	Sölvegatan 41 Lund SN 223 70 Sweden
Employees	-
Website	http://www.bioinvent.com
Updated	07/08/2019
BioInvent International AB engages in the research and development of immuno-regulatory antibodies to treat cancer. Its clinical programs include BI-1206 for non-Hodgkin's lymphoma and chronic lymphatic leukaemia; TB-403 for paediatric brain tumors; and THR-317 for diabetic macular edema. Its technology platforms consist of F.